Canvas Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$326K Buy
5,312
+758
+17% +$47.9K 0.04% 181
2026
Q2
$262K Buy
4,554
+724
+19% +$41.6K 0.04% 213
2026
Q1
$232K Buy
+3,830
New +$223K 0.04% 216

Other funds holding BMY

Canvas Wealth Advisors's BMY Position: Q3 2026 in Review

Canvas Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 17% in Q3 2026, buying an estimated $47.9K and bringing the position to 5,312 shares worth $326K. The position accounts for 0.04% of the portfolio, ranked #181.

Canvas Wealth Advisors first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Canvas Wealth Advisors held 5,312 shares of Bristol-Myers Squibb worth $326K as of Q3 2026.
  • Canvas Wealth Advisors bought 758 Bristol-Myers Squibb shares in Q3 2026, an estimated $47.9K.
  • Bristol-Myers Squibb made up 0.04% of Canvas Wealth Advisors's portfolio in Q3 2026, its #181 holding.
  • Canvas Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
  • 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Canvas Wealth Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.